Notice of AGM & Annual Report to 31 March 2026

Summary by AI BETAClose X

Cambridge Nutritional Sciences plc has announced the availability of its Notice of Annual General Meeting and Annual Report and Accounts for the year ended 31 March 2026 on its website. The company, an AIM-listed specialist medical diagnostics firm, will hold its AGM on Wednesday, 23 September 2026. This announcement provides shareholders with access to the company's financial performance and future strategic discussions.

Disclaimer*

Cambridge Nutritional Sciences PLC
08 September 2026
 

8 September 2026

Cambridge Nutritional Sciences plc

 

(the "Company" or "CNSL")

 

Notice of AGM and Annual Report to 31 March 2026

 

Cambridge Nutritional Sciences plc (AIM: CNSL), the specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition, confirms that the Notice of Annual General Meeting ('AGM') and the Annual Report and Accounts for the year ended 31 March 2026 are now available on the Company's website at:

 

https://www.cnsplc.com/financials/  

 

 

The Company's AGM will be held on Wednesday 23 September 2026 at 3.00pm at E-space North, 181 Wisbech, Littleport, Ely, CB6 1RA.

 

 

 

 

 

Contacts: 

Cambridge Nutritional Sciences plc        

www.cnsplc.com

Carolyn Rand, Non-Executive Chair

investors@cnsplc.com

James Cooper, Chief Executive Officer

 

Ajay Patel, Chief Financial Officer

 

 

Cavendish Capital Markets Limited    

 

Tel: 020 7220 0500

Geoff Nash / Edward Whiley / (Corporate Finance)

 

Nigel Birks / Harriet Ward (ECM)

 

 

 

 

 

About Cambridge Nutritional Sciences plc

Cambridge Nutritional Sciences plc (AIM: CNSL) is a specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings